Browse studies

Find your next paid study

57 recruiting studies matching your filters

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury: Randomized Controlled Trial

The objective is to determine the effectiveness of pulsatile flow during cardiopulmonary bypass to reduce the incidence of acute kidney injury after cardiac su…

Acute Kidney InjuryHemolysisThrombocytopenia+1 more

Estimated

~$10 – $6,250

University of Colorado, DenverNCT06349577

Development of a Peripheral Blood Assay to Replace BM Evaluation in Cytopenia - a Multi-Center Observational Study

This observational, multi-center study aims to collect data in order to develop a novel, minimally invasive diagnostic tool for MDS based on peripheral blood p…

CytopeniaMDS

Estimated

~$10 – $1,125

Weizmann Institute of ScienceNCT07081087

Prevalence, Reproducibility, and Feasibility of Longitudinal Assessment of Neurocognitive Dysfunction in Adults with Chronic and Persistent Immune Thrombocytopenia (COGFIT)

Individuals with immune thrombocytopenia (ITP) frequently report difficulties with attention and memory. The main question this study seeks to answer is: Do p…

Immune Thrombocytopenia

Estimated

~$10 – $750

Massachusetts General HospitalNCT06817395

Phase 2

Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia

The purpose of this study is to find out whether upfront emapalumab treatment can help in sAA (Aplastic Anemia) treatment planning and increase the effectivene…

Aplastic AnemiaCytopeniaHypocellular Marrow

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT06430788

Comparative Outcomes of Prothrombin Complex Concentrate and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion: A Retrospective Cohort Study

This study aims to compare the incidence of thromboembolic complications among trauma patients receiving PCC, rFVIIa, both agents, or neither during massive tr…

ThromboembolusMassive Blood Transfusion; ThrombocytopeniaTrauma

Estimated

~$10 – $1,125

Zeliha AlicikusNCT07290634

Phase 2

A Randomized Double-Blind Placebo-Controlled Phase II Multi-Center Study of Inflammation Modification of Canakinumab to Prevent Leukemic Progression of Clonal Cytopenias of Unknown Significance (CCUS): IMPACT Study

This phase II trial tests how well canakinumab works to prevent progression to cancer in patients with clonal cytopenias of unknown significance (CCUS). CCUS i…

Clonal Cytopenia of Undetermined Significance

Estimated

~$10 – $7,500

Uma BorateNCT05641831

Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation

This is a prospective observational study that was designed with the following two Specific Aims: 1. To determine whether the Immature Platelet Fraction perce…

Neonatal Thrombocytopenia

Estimated

~$10 – $750

Boston Children's HospitalNCT03848923

Phase 1

A Multi-Site Break Through Cancer Pilot Study Testing the Feasibility and Safety of Therapeutic Intervention for Patients With High-risk Clonal Cytopenia of Undetermined Significance (CCUS)

This research is being done to find out more about the potential risks and benefits of early treatment in participants with high risk Clonal Cytopenia of Unkno…

Clonal Cytopenia of Undetermined SignificanceCytopenia

Estimated

~$10 – $7,500

Lachelle D. Weeks, MD, PhDNCT06802146

Pharmacogenomics of Heparin-Induced Thrombocytopenia

The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to hep…

Heparin-induced Thrombocytopenia

Estimated

~$10 – $750

University of ArizonaNCT02717039